EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SynCraft: an integrated web server for ADMET-aware retrosynthesis and molecular design

Qahtan Adnan Aljanabi, Zhijian Huang iD, Jinmiao Song iD, Lei Deng iD

Nucleic Acids Research · 11.07.2026 · 54 (W1) · W57-W64

DOI: 10.1093/nar/gkag463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 14.05.2026. Verfasst von Qahtan Adnan Aljanabi und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer Science and Engineering, Central South University, Changsha 410083, China. Hauptthemen laut MEDLINE: Software, Drug Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficient design of drug candidates requires simultaneous consideration of synthetic feasibility and pharmacokinetic safety. However, current computational tools typically address retrosynthetic planning and ADMET evaluation as separate tasks, requiring users to manually transfer data between platforms and evaluate candidate molecules in a sequential and time-consuming manner. Here, we present SynCraft, a web server that integrates template-based retrosynthesis with real-time ADMET evaluation within a unified workflow. SynCraft accepts molecular input via SMILES, interactive drawing, or file upload, and performs automated multi-step retrosynthetic planning while simultaneously assessing the safety and drug-likeness of all intermediate compounds. ADMET properties are predicted using a multi-view learning framework, and potentially hazardous intermediates are automatically highlighted with intuitive, colour-coded warnings during route exploration. The server further provides integrated analysis tools, including synthetic accessibility and complexity scoring, drug-likeness evaluation, and interactive 2D/3D visualization, enabling users to seamlessly transition from route generation to detailed molecular assessment. Results are presented through an interactive interface that allows comparison of alternative synthetic routes, with downloadable outputs in standard formats. In a case study of imatinib, SynCraft automatically identifies genotoxic intermediates that are typically overlooked in conventional retrosynthesis workflows, demonstrating its practical utility for safety-aware route design. The web server is freely accessible at https://syncraft.denglab.org.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SoftwareDrug DesignInternetImatinib MesylateUser-Computer Interface

Substanzen

Imatinib Mesylate

Autor:innen und Institutionen

  • School of Computer Science and Engineering, Central South University, Changsha 410083, China.
  • School of Software, Xinjiang University, Urumqi 830046, China.

ORCID-Profile: Zhijian Huang, Jinmiao Song, Lei Deng

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Aljanabi, Q. A., Huang, Z., Song, J., & Deng, L. (2026). SynCraft: an integrated web server for ADMET-aware retrosynthesis and molecular design. Nucleic Acids Research, 54(W1), W57-W64. https://doi.org/10.1093/nar/gkag463

Vancouver

Aljanabi QA, Huang Z, Song J, Deng L. SynCraft: an integrated web server for ADMET-aware retrosynthesis and molecular design. Nucleic Acids Research. 2026;54(W1):W57-W64. doi:10.1093/nar/gkag463

BibTeX
@article{Aljanabi2026,
  author = {Aljanabi, Qahtan Adnan and Huang, Zhijian and Song, Jinmiao and Deng, Lei},
  title = {SynCraft: an integrated web server for ADMET-aware retrosynthesis and molecular design},
  journal = {Nucleic Acids Research},
  year = {2026},
  volume = {54},
  number = {W1},
  pages = {W57--W64},
  doi = {10.1093/nar/gkag463}
}
Kostenlos starten →